Kim Seok Jai, Yoo Kyung Yeon, Park Byoung Yun, Kim Woong Mo, Jeong Cheol Won
Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School, Gwangju, Korea.
Korean J Anesthesiol. 2009 Jul;57(1):13-19. doi: 10.4097/kjae.2009.57.1.13.
We compared the effects of different remifentanil effect-site concentrations on intubating conditions, and cardiovascular and bispectral index score (BIS) responses to intubation at a fixed effect-site concentration of propofol without muscle relaxants.
Sixty-four patients were randomly assigned to one of three groups: remifentanil 2 (group R2, n = 22), 4 (group R4, n = 21), or 6 ng/ml (group R6, n = 21). Anesthesia was induced using target-controlled infusion of propofol 5 microgram/ml and each concentration of remifentanil. Laryngoscopy and intubation was attempted at 2.5 min following induction. Intubating conditions were assessed as excellent, good or poor using a standard scoring system. Mean arterial pressure (MAP), heart rate (HR), and BIS values were assessed.
Excellent or good intubating conditions were obtained in 91% of group R4 and 95% of R6, both of which are higher compared with 32% of R2 (P < 0.01). MAP and HR decreased significantly after induction in all groups. After intubation, they recovered to baseline value in group R2 and R4 but were significantly less than baseline values in R6. BIS response to intubation was attenuated in group R4 and R6 but not R2. Hypotension was more frequent in group R6 than R2.
Remifentanil target concentrations of 4 or 6 ng/ml combined with 5 microgram/ml propofol provided good or excellent conditions for tracheal intubation and prevented cardiovascular and BIS response during induction without muscle relaxants. However, the use of 6 ng/ml dose was associated with frequent occurrence of hypotension and bradycardia requiring treatment.
我们比较了不同瑞芬太尼效应室浓度对插管条件以及在丙泊酚效应室浓度固定且未使用肌肉松弛剂的情况下插管时心血管反应和脑电双频指数(BIS)评分的影响。
64例患者被随机分为三组之一:瑞芬太尼2 ng/ml(R2组,n = 22)、4 ng/ml(R4组,n = 21)或6 ng/ml(R6组,n = 21)。采用靶控输注5微克/毫升丙泊酚和各浓度瑞芬太尼诱导麻醉。诱导后2.5分钟尝试喉镜检查和插管。使用标准评分系统将插管条件评估为优、良或差。评估平均动脉压(MAP)、心率(HR)和BIS值。
R4组91%和R6组95%获得了优或良的插管条件,两者均高于R2组的32%(P < 0.01)。所有组诱导后MAP和HR均显著下降。插管后,R2组和R4组恢复至基线值,但R6组显著低于基线值。R4组和R6组对插管的BIS反应减弱,但R2组未减弱。R6组低血压比R2组更常见。
4或6 ng/ml的瑞芬太尼靶浓度与5微克/毫升丙泊酚联合使用可为气管插管提供良好或优的条件,并在未使用肌肉松弛剂的诱导过程中预防心血管和BIS反应。然而,使用6 ng/ml剂量与需要治疗的低血压和心动过缓频繁发生有关。